Objective: The study was undertaken to evaluate the levonorgestrel-releasing intrauterine system (LNG-IUS)in managing menorrhagia associated with hemostatic disorders. Study design: Retrospective notes review. Results...Objective: The study was undertaken to evaluate the levonorgestrel-releasing intrauterine system (LNG-IUS)in managing menorrhagia associated with hemostatic disorders. Study design: Retrospective notes review. Results: Nineteen of 28 (68%) patients experienced improvement with the LNG-IUS. There was nonacceptance by 9 of 28 (32%) who refused the LNG-IUS or had it definitively removed. Conclusion: The LNG-IUS should be considered when managing menorrhagia because surgery carries additional risks in this subset of patients.展开更多
文摘Objective: The study was undertaken to evaluate the levonorgestrel-releasing intrauterine system (LNG-IUS)in managing menorrhagia associated with hemostatic disorders. Study design: Retrospective notes review. Results: Nineteen of 28 (68%) patients experienced improvement with the LNG-IUS. There was nonacceptance by 9 of 28 (32%) who refused the LNG-IUS or had it definitively removed. Conclusion: The LNG-IUS should be considered when managing menorrhagia because surgery carries additional risks in this subset of patients.
